Crossmark

MiNEN, amphicrine carcinomas, and conventional carcinomas with neuroendocrine differentiation: diagnostic criteria, open questions, and future perspectives

Crossref DOI link: https://doi.org/10.1007/s00428-025-04241-z

Published Online: 2025-09-11

Published Print: 2026-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jesinghaus, Moritz https://orcid.org/0000-0002-0018-5661
Schmitt, Maxime Philipp

Foersch, Sebastian

Konukiewitz, Björn
Funding

Funding for this research was provided by:

Deutsche Krebshilfe (Project-ID 360372040)

Deutsche Krebshilfe (70115166)

BMBF (SWAG)

BMBF (01KD2215C)

BMBF (DECIPHER-M)

BMBF (01KD2420E)

Deutsche Forschungsgemeinschaft (504101714)

Philipps-Universität Marburg
License Information

Text and Data Mining valid from 2025-09-11

Version of Record valid from 2025-09-11
More Information

Article History

Received: 27 June 2025

Revised: 1 August 2025

Accepted: 18 August 2025

First Online: 11 September 2025

Declarations

:

: This review was created in compliance with ethical standards, including the declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below